Who backs Artios?
27 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| Sofinnova Partners | Venture capital |
| M Ventures | Venture capital |
| The Invus Group | PE / buyout |
| SV Health Investors | Venture capital |
| EQT Life Sciences | Venture capital |
| Pfizer Ventures | Other |
| Andera Partners | PE / buyout |
| Schroders Capital | Other |
| Novartis Venture Fund | Other |
| + 17 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Artios investors
27 investors are on record for Artios, including RA Capital Management, Sofinnova Partners, M Ventures and The Invus Group. By type, the record holds 5 venture capital firms and 4 private equity firms. The Series D in Nov 2025 drew 15 investors.
Free account
More of Artios with a free account
- ·The complete investor list: 27 names
- ·Watch Artios: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 27 firms already write checks for companies like Artios in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View